FDA Inspection
Smith & Nephew Wound ManagementSmith & Nephew Wound Management – FDA Inspection, Feb 26, 2026
Record Details
This FDA Inspection record concerns Smith & Nephew Wound Management, with an inspection on February 26, 2026, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · 57fdd3fa-44fe-453a-9929-805bbe93b9eb
Inspection Facts
- Inspection number
- 1304660
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.84(a)Components withheld from use pending release
- 21 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Smith & Nephew Wound Management
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 29, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Smith & Nephew Wound Management
- FDA Inspection 1060515 - 2018-06-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.